GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Loans Receivable

Vaxil Bio (TSXV:VXL) Loans Receivable : C$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Loans Receivable?

Vaxil Bio's Loans Receivable for the quarter that ended in Dec. 2023 was C$0.00 Mil.


Vaxil Bio Loans Receivable Historical Data

The historical data trend for Vaxil Bio's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio Loans Receivable Chart

Vaxil Bio Annual Data
Trend May14 May15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vaxil Bio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vaxil Bio Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Vaxil Bio Loans Receivable Related Terms

Thank you for viewing the detailed overview of Vaxil Bio's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxil Bio (TSXV:VXL) Business Description

Traded in Other Exchanges
Address
C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Vaxil Bio (TSXV:VXL) Headlines

No Headlines